Correlation Between Biotechnology Ultrasector and Brown Advisory

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotechnology Ultrasector and Brown Advisory at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Ultrasector and Brown Advisory into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Ultrasector Profund and Brown Advisory Intermediate, you can compare the effects of market volatilities on Biotechnology Ultrasector and Brown Advisory and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Ultrasector with a short position of Brown Advisory. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Ultrasector and Brown Advisory.

Diversification Opportunities for Biotechnology Ultrasector and Brown Advisory

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between Biotechnology and Brown is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Ultrasector Prof and Brown Advisory Intermediate in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brown Advisory Inter and Biotechnology Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Ultrasector Profund are associated (or correlated) with Brown Advisory. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brown Advisory Inter has no effect on the direction of Biotechnology Ultrasector i.e., Biotechnology Ultrasector and Brown Advisory go up and down completely randomly.

Pair Corralation between Biotechnology Ultrasector and Brown Advisory

Assuming the 90 days horizon Biotechnology Ultrasector Profund is expected to generate 7.6 times more return on investment than Brown Advisory. However, Biotechnology Ultrasector is 7.6 times more volatile than Brown Advisory Intermediate. It trades about 0.02 of its potential returns per unit of risk. Brown Advisory Intermediate is currently generating about 0.04 per unit of risk. If you would invest  6,115  in Biotechnology Ultrasector Profund on September 12, 2024 and sell it today you would earn a total of  500.00  from holding Biotechnology Ultrasector Profund or generate 8.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Biotechnology Ultrasector Prof  vs.  Brown Advisory Intermediate

 Performance 
       Timeline  
Biotechnology Ultrasector 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotechnology Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Biotechnology Ultrasector is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Brown Advisory Inter 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Brown Advisory Intermediate has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Brown Advisory is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Biotechnology Ultrasector and Brown Advisory Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotechnology Ultrasector and Brown Advisory

The main advantage of trading using opposite Biotechnology Ultrasector and Brown Advisory positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Ultrasector position performs unexpectedly, Brown Advisory can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brown Advisory will offset losses from the drop in Brown Advisory's long position.
The idea behind Biotechnology Ultrasector Profund and Brown Advisory Intermediate pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets